210:
quality studies and those conducted outside the US and EU were less likely to be below this threshold. While the two conclusions of this article may indicate that industry-funded ICER measures are lower methodological quality than those published by non-industry sources, there is also a possibility that, due to the nature of retrospective or other non-public work, publication bias may exist rather than methodology biases. There may be incentive for an organization not to develop or publish an analysis that does not demonstrate the value of their product. Additionally, peer reviewed journal articles should have a strong and defendable methodology, as that is the expectation of the peer-review process.
36:
209:
A 1995 study of the cost-effectiveness of reviewed over 500 life-saving interventions found that the median cost-effectiveness was $ 42,000 per life-year saved. A 2006 systematic review found that industry-funded studies often concluded with cost-effective ratios below $ 20,000 per QALY and low
89:
health effect. Typically the CEA is expressed in terms of a ratio where the denominator is a gain in health from a measure (years of life, premature births averted, sight-years gained) and the numerator is the cost associated with the health gain. The most commonly used outcome measure is
108:
extends the core methods of CEA to incorporate concerns for the distribution of outcomes as well as their average level and make trade-offs between equity and efficiency, these more sophisticated methods are of particular interest when analysing interventions to tackle
222:
investments in buildings to calculate the value of energy saved in $ /kWh. The energy in such a calculation is virtual in the sense that it was never consumed but rather saved due to some energy efficiency investment being made. Such savings are sometimes called
175:, the cost-effectiveness of a therapeutic or preventive intervention is the ratio of the cost of the intervention to a relevant measure of its effect. Cost refers to the resource expended for the intervention, usually measured in monetary terms such as
229:. The benefit of the CEA approach in energy systems is that it avoids the need to guess future energy prices for the purposes of the calculation, thus removing the major source of uncertainty in the appraisal of energy efficiency investments.
145:
of their guns. If a tank's performance in these areas is equal or even slightly inferior to its competitor, but substantially less expensive and easier to produce, military planners may select it as more cost-effective than the competitor.
206:(ICER), the ratio of change in costs to the change in effects. A complete compilation of cost-utility analyses in the peer-reviewed medical and public health literature is available from the Cost-Effectiveness Analysis Registry website.
187:
and the number of symptom-free days experienced by a patient. The selection of the appropriate effect measure should be based on clinical judgment in the context of the intervention being considered.
777:
256:
85:, which assigns a monetary value to the measure of effect. Cost-effectiveness analysis is often used in the field of health services, where it may be inappropriate to
183:. The measure of effects depends on the intervention being considered. Examples include the number of people cured of a disease, the mm Hg reduction in diastolic
672:
149:
Conversely, if the difference in price is near zero, but the more costly competitor would convey an enormous battlefield advantage through special ammunition,
104:, the cost represented on one axis and the effectiveness on the other axis. Cost-effectiveness analysis focuses on maximising the average level of an outcome,
163:, enabling it to destroy enemy tanks accurately at extreme ranges, military planners may choose it instead – based on the same cost-effectiveness principle.
121:
The concept of cost-effectiveness is applied to the planning and management of many types of organized activity. It is widely used in many aspects of life.
262:
105:
772:
436:"Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme"
834:
793:
203:
751:
824:
81:
that compares the relative costs and outcomes (effects) of different courses of action. Cost-effectiveness analysis is distinct from
665:
50:
499:
Tengs TO, Adams ME, Pliskin JS, et al. (June 1995). "Five-hundred life-saving interventions and their cost-effectiveness".
287:"Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost–benefit analysis?"
829:
199:
875:
658:
133:, for example, competing designs are compared not only for purchase price, but also for such factors as their operating
870:
100:
is similar to cost-effectiveness analysis. Cost-effectiveness analyses are often visualized on a plane consisting of
880:
839:
803:
731:
195:
91:
238:
191:
97:
82:
865:
435:
101:
746:
741:
695:
479:
767:
583:
Tuominen, Pekka; Reda, Francesco; Dawoud, Waled; Elboshy, Bahaa; Elshafei, Ghada; Negm, Abdelazim (2015).
641:
ISPOR-CO, The
Colombian Chapter of The International Society for Pharmacoeconomics and Outcomes Research
142:
726:
219:
736:
681:
153:
808:
367:
194:, where the effects are measured in terms of years of full health lived, using a measure such as
705:
700:
565:
516:
460:
416:
359:
309:
172:
110:
78:
27:
Economic analysis that compares the relative costs and outcomes of different courses of action
619:
286:
596:
555:
547:
508:
450:
406:
398:
351:
301:
585:"Economic Appraisal of Energy Efficiency in Buildings Using Cost-effectiveness Assessment"
49:
Please expand the article to include this information. Further details may exist on the
860:
721:
560:
535:
512:
411:
386:
184:
180:
601:
584:
305:
241: – Systematic approach to estimating the strengths and weaknesses of alternatives
854:
160:
636:
World Health
Organization – CHOICE (Choosing Interventions that are Cost Effective)
371:
244:
138:
17:
629:
551:
355:
250:
402:
569:
464:
420:
342:
Black, William (1990). "A Graphical
Representation of Cost-Effectiveness".
313:
35:
624:
520:
363:
259: – Non-departmental public body of the Department of Health in the UK
640:
225:
86:
434:
Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P (June 2015).
650:
455:
176:
134:
157:
150:
635:
536:"Bias in published cost effectiveness studies: systematic review"
130:
654:
645:
247: – Unexpected incurred costs in excess of budgeted amounts
253: – Degree to which a process minimizes waste of resources
29:
778:
List of international healthcare accreditation organizations
387:"Distributional Cost-Effectiveness Analysis: A Tutorial"
478:
Center for the
Evaluation of Value and Risk in Health.
646:
International Cost
Estimating and Analysis Association
534:
Bell CM, Urbach DR, Ray JG, et al. (March 2006).
817:
786:
760:
714:
688:
625:Global Health Cost-Effectiveness Analysis Registry
385:Asaria, M; Griffin, S; Cookson, R (January 2016).
202:. Cost-effectiveness is typically expressed as an
257:National Institute for Health and Care Excellence
666:
8:
673:
659:
651:
480:"The Cost-Effectiveness Analysis Registry"
263:Distributional cost-effectiveness analysis
141:, armor protection, and caliber and armor
106:distributional cost-effectiveness analysis
600:
559:
454:
410:
329:Cost-effectiveness in health and medicine
285:Bleichrodt H, Quiggin J (December 1999).
280:
278:
274:
773:International healthcare accreditation
7:
835:Incremental cost-effectiveness ratio
794:Incremental cost-effectiveness ratio
204:incremental cost-effectiveness ratio
752:Routine health outcomes measurement
825:Clinical Quality Management System
513:10.1111/j.1539-6924.1995.tb00330.x
25:
214:In energy efficiency investments
34:
630:Why some drugs are not worth it
129:In the acquisition of military
589:Procedia Economics and Finance
200:disability-adjusted life years
1:
830:Disability-adjusted life year
602:10.1016/S2212-5671(15)00195-1
306:10.1016/S0167-6296(99)00014-4
799:Cost-effectiveness analysis
552:10.1136/bmj.38737.607558.80
196:quality-adjusted life years
92:quality-adjusted life years
71:Cost-effectiveness analysis
897:
840:Quality-adjusted life year
804:Cost-minimization analysis
732:Independent medical review
356:10.1177/0272989x9001000308
190:A special case of CEA is
747:Health services research
742:Health impact assessment
403:10.1177/0272989x15583266
218:CEA has been applied to
125:In military acquisitions
715:Health care evaluations
696:Evidence-based medicine
391:Medical Decision Making
768:Hospital accreditation
45:is missing information
327:Gold MR; et al.
239:Cost–benefit analysis
192:cost–utility analysis
98:Cost–utility analysis
83:cost–benefit analysis
727:Clinical peer review
167:In pharmacoeconomics
876:Health care quality
737:Health care ratings
689:Concepts of quality
682:Health care quality
871:Health informatics
809:Cost per procedure
787:Costs and benefits
620:Tufts CEA Registry
171:In the context of
47:about calculation.
18:Cost-effectiveness
881:Decision analysis
848:
847:
706:Medical guideline
701:Medical consensus
546:(7543): 699–703.
220:energy efficiency
173:pharmacoeconomics
111:health inequality
79:economic analysis
68:
67:
16:(Redirected from
888:
866:Health economics
675:
668:
661:
652:
607:
606:
604:
580:
574:
573:
563:
531:
525:
524:
496:
490:
489:
487:
486:
475:
469:
468:
458:
456:10.1002/hec.3058
443:Health Economics
440:
431:
425:
424:
414:
382:
376:
375:
344:Med Decis Making
339:
333:
332:
331:. p. xviii.
324:
318:
317:
291:
282:
63:
60:
54:
38:
30:
21:
896:
895:
891:
890:
889:
887:
886:
885:
851:
850:
849:
844:
813:
782:
756:
710:
684:
679:
616:
611:
610:
582:
581:
577:
533:
532:
528:
498:
497:
493:
484:
482:
477:
476:
472:
438:
433:
432:
428:
384:
383:
379:
341:
340:
336:
326:
325:
321:
289:
284:
283:
276:
271:
235:
216:
169:
127:
119:
77:) is a form of
64:
58:
55:
48:
39:
28:
23:
22:
15:
12:
11:
5:
894:
892:
884:
883:
878:
873:
868:
863:
853:
852:
846:
845:
843:
842:
837:
832:
827:
821:
819:
815:
814:
812:
811:
806:
801:
796:
790:
788:
784:
783:
781:
780:
775:
770:
764:
762:
758:
757:
755:
754:
749:
744:
739:
734:
729:
724:
722:Clinical audit
718:
716:
712:
711:
709:
708:
703:
698:
692:
690:
686:
685:
680:
678:
677:
670:
663:
655:
649:
648:
643:
638:
633:
627:
622:
615:
614:External links
612:
609:
608:
575:
526:
491:
470:
426:
377:
350:(3): 212–214.
334:
319:
300:(6): 681–708.
273:
272:
270:
267:
266:
265:
260:
254:
248:
242:
234:
231:
215:
212:
185:blood pressure
168:
165:
126:
123:
118:
115:
102:four quadrants
66:
65:
42:
40:
33:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
893:
882:
879:
877:
874:
872:
869:
867:
864:
862:
859:
858:
856:
841:
838:
836:
833:
831:
828:
826:
823:
822:
820:
816:
810:
807:
805:
802:
800:
797:
795:
792:
791:
789:
785:
779:
776:
774:
771:
769:
766:
765:
763:
761:Accreditation
759:
753:
750:
748:
745:
743:
740:
738:
735:
733:
730:
728:
725:
723:
720:
719:
717:
713:
707:
704:
702:
699:
697:
694:
693:
691:
687:
683:
676:
671:
669:
664:
662:
657:
656:
653:
647:
644:
642:
639:
637:
634:
631:
628:
626:
623:
621:
618:
617:
613:
603:
598:
594:
590:
586:
579:
576:
571:
567:
562:
557:
553:
549:
545:
541:
537:
530:
527:
522:
518:
514:
510:
507:(3): 369–90.
506:
502:
495:
492:
481:
474:
471:
466:
462:
457:
452:
449:(6): 742–54.
448:
444:
437:
430:
427:
422:
418:
413:
408:
404:
400:
396:
392:
388:
381:
378:
373:
369:
365:
361:
357:
353:
349:
345:
338:
335:
330:
323:
320:
315:
311:
307:
303:
299:
295:
294:J Health Econ
288:
281:
279:
275:
268:
264:
261:
258:
255:
252:
249:
246:
243:
240:
237:
236:
232:
230:
228:
227:
221:
213:
211:
207:
205:
201:
197:
193:
188:
186:
182:
178:
174:
166:
164:
162:
161:range finding
159:
155:
152:
147:
144:
140:
137:, top speed,
136:
132:
124:
122:
116:
114:
112:
107:
103:
99:
95:
93:
88:
84:
80:
76:
72:
62:
59:November 2022
52:
46:
43:This article
41:
37:
32:
31:
19:
798:
592:
588:
578:
543:
539:
529:
504:
500:
494:
483:. Retrieved
473:
446:
442:
429:
394:
390:
380:
347:
343:
337:
328:
322:
297:
293:
245:Cost overrun
224:
217:
208:
189:
170:
154:fire control
148:
139:rate of fire
128:
120:
117:Applications
96:
74:
70:
69:
56:
44:
595:: 422–430.
397:(1): 8–19.
143:penetration
855:Categories
632:BBC report
485:2020-09-04
269:References
251:Efficiency
198:(QALY) or
501:Risk Anal
226:negawatts
51:talk page
570:16495332
465:24798212
421:25908564
314:10847930
233:See also
94:(QALY).
87:monetize
561:1410902
521:7604170
412:4853814
372:2056683
364:2115096
177:dollars
568:
558:
519:
463:
419:
409:
370:
362:
312:
181:pounds
135:radius
861:Costs
818:Tools
439:(PDF)
368:S2CID
290:(PDF)
158:laser
151:radar
131:tanks
566:PMID
517:PMID
461:PMID
417:PMID
360:PMID
310:PMID
156:and
597:doi
556:PMC
548:doi
544:332
540:BMJ
509:doi
451:doi
407:PMC
399:doi
352:doi
302:doi
179:or
75:CEA
857::
593:21
591:.
587:.
564:.
554:.
542:.
538:.
515:.
505:15
503:.
459:.
447:24
445:.
441:.
415:.
405:.
395:36
393:.
389:.
366:.
358:.
348:10
346:.
308:.
298:18
296:.
292:.
277:^
113:.
674:e
667:t
660:v
605:.
599::
572:.
550::
523:.
511::
488:.
467:.
453::
423:.
401::
374:.
354::
316:.
304::
73:(
61:)
57:(
53:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
